82096-91-1

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-4-Trifluoromethylbenzaldehyde is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-4-Trifluoromethylbenzaldehyde is employed as an intermediate in the production of agrochemicals, potentially enhancing crop protection and yield through the development of novel compounds.
Used in Organic Synthesis:
2-Chloro-4-Trifluoromethylbenzaldehyde is utilized as an intermediate in organic synthesis, allowing for the creation of a variety of organic compounds with diverse applications across different industries.

Upstream product

• 56456-51-0 (2-chloro-4-(trifluoromethyl)phenyl)methanol 
• 98-15-7 3-chlorotrifluoromethylbenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 1813-33-8 2-chloro-4-trifluoromethyl-benzonitril 

Downstream Products

• 140919-39-7 2-[2-chloro-4-(trifluoromethyl)phenyl]-6-nitro-1,3-benzoxathian 
• 13754-78-4 dihydrobenzoxathiin 
• 1188445-87-5 2-chloro-4-(trifluoromethyl)benzaldehyde oxime 
• 1202890-35-4 (E)-2-chloro-1-(2-nitrovinyl)-4-(trifluoromethyl)benzene 
• 1246376-26-0 2-(2-chloro-4-(trifluoromethyl)phenyl)-6-methyl-2H-pyran-4(3H)-one 
• 1422127-51-2 C₂₁H₂₅ClF₃N₃O₂S 
• 1422127-46-5 C₂₀H₁₉ClF₃N₃OS 
• 1160183-82-3 2-(2-chloro-4-(trifluoromethyl)phenyl)ethanamine 

Relevant academic research and scientific papers

TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS

The present invention is directed to pyrimidine carboxamide compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE

The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention of metabolic, cardiovascular, and metabolic diseases.

6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES

Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

1-(HETERO)ARYL-3-AMINO-PYROLLIDINE DERIVATIVES FOR USE AS MGLUR3 RECEPTOR ANTAGONISTS

The present invention relates to compounds of the Formula (I) which are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia and migraine, pharmaceutical compositions thereof, and methods of using the same.